🇺🇸 FDA
Patent

US 10398772

Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy

granted A61KA61K2039/53A61K2039/55505

Quick answer

US patent 10398772 (Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/53, A61K2039/55505, A61K2039/55516, A61K2039/55566